Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, announces that it […]
Targeted immunotherapy could lead to pioneering treatment for breast cancer
A new type of immunotherapy that targets non-cancer cells could help prevent the growth and spread of breast cancer tumours, according to new research funded by Breast Cancer Now. The […]
New AI collaboration could advance precision therapy in breast cancer
A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast cancer […]
UCLH to focus on trials of personalised cancer treatments
Among the many cancer clinical trials opening each year at University College London Hospitals, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies. […]
Adding radiation to lung cancer treatment improves outcomes
A new study has found patients with non-small cell lung cancer treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy […]
Researchers uncover on/off switch for breast cancer metastasis
New research from Stanford University and the Arc Institute in the US could lead to a new and more effective immunotherapy and help clinicians better predict patient response to existing […]
Immunotherapy shows promise as a kinder first-line treatment for advanced head and neck cancers
Immunotherapy can extend the response of some head and neck tumours to treatment, maintaining the anti-tumour effects and preventing them from growing or spreading for longer, a study reports. A […]
Immunotherapy improves long-term survival for advanced stage non-small cell lung cancer patients
A global study, led by UCLH and UCL and sponsored by Roche, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival of advanced stage non-small cell lung […]
Pioneering digital fitness drive for Clatterbridge cancer patients
Clatterbridge cancer patients awaiting immunotherapy have the chance to get fitter and improve their chances of successful treatment through a partnership with the hospital and a university. The new pilot […]
New research reveals neutrophils play key role in determining success of cancer immunotherapy
Cancer immunotherapies that recruit a patient’s own immune system to destroy tumours have transformed the treatment of many types of cancer. Yet these therapies do not elicit universally good treatment […]
